Clifford Chance advises Keensight Capital on raising circa €3 billion to invest in European Technology and Healthcare companies

Keensight Capital, one of the leading private equity managers dedicated to European Growth Buyout investments, has raised €2.8 billion in funds to invest in leading Technology and Healthcare companies.

Keensight Capital’s recent fundraise was significantly oversubscribed, with strong support from existing LPs, as well as new investors from Europe, North America, the Middle East, and Asia. This globally diverse LP base generated c.90% of subscriptions from institutional investors (asset managers, pension funds, insurance companies, banks and sovereign wealth funds), and c.10% from former portfolio company CEOs and family offices.

Keensight Capital will continue to pursue its consistent and successful investment strategy as a leader of European Growth Buyouts.

The Clifford Chance team was composed of Xavier Comaills, partner, as well as Louis-Guillaume Cousin and Patrick Biancaniello, associates.